Cargando…
Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients
The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the seco...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353019/ https://www.ncbi.nlm.nih.gov/pubmed/32585797 http://dx.doi.org/10.3390/cancers12061658 |
_version_ | 1783557777081237504 |
---|---|
author | Medas, Fabio Canu, Gian Luigi Cappellacci, Federico Anedda, Giacomo Conzo, Giovanni Erdas, Enrico Calò, Pietro Giorgio |
author_facet | Medas, Fabio Canu, Gian Luigi Cappellacci, Federico Anedda, Giacomo Conzo, Giovanni Erdas, Enrico Calò, Pietro Giorgio |
author_sort | Medas, Fabio |
collection | PubMed |
description | The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the secondary goal was to estimate the incidence of postoperative complications in patients who underwent pCLND and to evaluate the prognostic value of occult node metastases. In this retrospective study, we included patients with preoperative diagnosis of DTC and clinically uninvolved lymph nodes (cN0). The patients were divided into two groups, depending on the surgical approach: total thyroidectomy alone (TT group) or total thyroidectomy and pCLND (pCLND group). Three hundred and ninety-nine patients were included in this study, 320 (80.2%) in the TT group and 79 (19.8%) in the pCLND group. There were no significant differences in morbidity among the two groups. Histopathological evaluation demonstrated a similar distribution of aggressive features, especially regarding multicentricity, extrathyroidal extension, and angioinvasivity between the two groups. Occult lymph node metastases were found in 20 (25.3%) patients in the pCLND group. Prophylactic CLND was effective in improving disease-free survival in patients with intermediate and high risk of disease recurrence (p = 0.0392); occult lymph node metastases resulted as a significant negative prognostic factor (p < 0.001). |
format | Online Article Text |
id | pubmed-7353019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73530192020-07-15 Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients Medas, Fabio Canu, Gian Luigi Cappellacci, Federico Anedda, Giacomo Conzo, Giovanni Erdas, Enrico Calò, Pietro Giorgio Cancers (Basel) Article The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the secondary goal was to estimate the incidence of postoperative complications in patients who underwent pCLND and to evaluate the prognostic value of occult node metastases. In this retrospective study, we included patients with preoperative diagnosis of DTC and clinically uninvolved lymph nodes (cN0). The patients were divided into two groups, depending on the surgical approach: total thyroidectomy alone (TT group) or total thyroidectomy and pCLND (pCLND group). Three hundred and ninety-nine patients were included in this study, 320 (80.2%) in the TT group and 79 (19.8%) in the pCLND group. There were no significant differences in morbidity among the two groups. Histopathological evaluation demonstrated a similar distribution of aggressive features, especially regarding multicentricity, extrathyroidal extension, and angioinvasivity between the two groups. Occult lymph node metastases were found in 20 (25.3%) patients in the pCLND group. Prophylactic CLND was effective in improving disease-free survival in patients with intermediate and high risk of disease recurrence (p = 0.0392); occult lymph node metastases resulted as a significant negative prognostic factor (p < 0.001). MDPI 2020-06-23 /pmc/articles/PMC7353019/ /pubmed/32585797 http://dx.doi.org/10.3390/cancers12061658 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Medas, Fabio Canu, Gian Luigi Cappellacci, Federico Anedda, Giacomo Conzo, Giovanni Erdas, Enrico Calò, Pietro Giorgio Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title | Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title_full | Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title_fullStr | Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title_full_unstemmed | Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title_short | Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients |
title_sort | prophylactic central lymph node dissection improves disease-free survival in patients with intermediate and high risk differentiated thyroid carcinoma: a retrospective analysis on 399 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353019/ https://www.ncbi.nlm.nih.gov/pubmed/32585797 http://dx.doi.org/10.3390/cancers12061658 |
work_keys_str_mv | AT medasfabio prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT canugianluigi prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT cappellaccifederico prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT aneddagiacomo prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT conzogiovanni prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT erdasenrico prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients AT calopietrogiorgio prophylacticcentrallymphnodedissectionimprovesdiseasefreesurvivalinpatientswithintermediateandhighriskdifferentiatedthyroidcarcinomaaretrospectiveanalysison399patients |